Nutraceutical NaturalCare, children's, Allergy Care, Homeopathic, 4 Months and Up, Liquid recall — FDA D-0440-2023
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Non-Sterility
Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
Chemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits.
Ford Motor Company (Ford) is recalling certain 2023 Maverick vehicles. A missing electrical circuit may cause the trailer taillights to not illuminate as intended when utilizing the vehicle…
Ford Motor Company (Ford) is recalling certain 2021-2022 Bronco vehicles equipped with 8-inch SYNC infotainment screens that were previously remedied under recall 22V-825. The rearview…
Ford Motor Company (Ford) is recalling certain 2021 F-150 vehicles. The windshield wiper arms may break, causing the windshield wipers to fail.
Honda (American Honda Motor Co.) is recalling certain 2017-2020 CR-V, 2018-2019 Accord and Accord Hybrid, 2018-2020 Odyssey, 2019 Insight, and 2019-2020 Acura RDX vehicles. A manufacturing…
Ford Motor Company (Ford) is recalling certain 2023 Bronco Wildtrak and 2022 Bronco Raptor vehicles. Internal damage to the steering gear may require increased steering effort or cause the…
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
Lack of Assurance of Sterility
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
Browse recent months with enough recall history for useful comparison.